ClinicalTrials.Veeva

Menu

Eye Patch Therapy for Central Serous Retinopathy (CSR)

The Washington University logo

The Washington University

Status and phase

Completed
Phase 1

Conditions

Central Serous Retinopathy (CSR)

Treatments

Device: Eye Patching

Study type

Interventional

Funder types

Other

Identifiers

NCT02036632
201211016

Details and patient eligibility

About

First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will aid in ameliorating disease severity and disease duration.

Enrollment

12 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults 18 years of age and older
  • Both males and females
  • Patients diagnosed with active central serous retinopathy
  • Patients who are willing to use an eye patch in the affected eye for 24 hours
  • Patients who are able to make the follow up appointments as required by the study

Exclusion criteria

  • Individuals under 18 years of age
  • Patients with vision less than 20/40 in the unaffected eye.
  • Patients who are not able to undergo mfERG testing in a realiable manner.

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

Eye Patching
Other group
Description:
Intervention
Treatment:
Device: Eye Patching

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems